Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 11;46(1):239.
doi: 10.1007/s10143-023-02130-0.

Middle meningeal artery embolization and pediatric chronic subdural hematoma: a systematic review of the literature

Andre Marolop Pangihutan Siahaan  1 , Suzy Indharty  2 , Steven Tandean  2 , Thomas Tommy  3 , Michael Lumintang Loe  4 , Bahagia Willibrordus Maria Nainggolan  5 , Dimas Pangestu  5 , Martin Susanto  5
Affiliations

Middle meningeal artery embolization and pediatric chronic subdural hematoma: a systematic review of the literature

Andre Marolop Pangihutan Siahaan et al. Neurosurg Rev. .

Abstract

Chronic subdural hematoma (CSDH) is a disease commonly found in the elderly and not a typical finding in pediatric population. History of shunt surgery, child abuse, and blood disorder are some of the common causes of pediatric CSDH (pCSDH). There is growing evidence about the role of middle meningeal artery embolization (MMAE) to manage CSDH in the elderly population with a high risk of rebleeding. However, the evidence in the pediatric population is still sparse. A systematic literature search was conducted on PubMed, Scopus, and Web of Science database from January, 2023, to March, 2023. Search strings were generated based on the combination of modified search terms, such as CSDH, MMA embolization, and child. Risk of bias was assessed using the Cochrane Risk of Bias in Nonrandomized Study for Intervention. Nine articles were included in this review. The success rate of MMA embolization in pediatric CSDH was 88.8%. Histories of ventriculoperitoneal shunt, blood coagulation disorder, and trauma were the causes of CSDH. Time to achieve success was varied from 2 to 9 months. No study with low risk of bias was found. This systematic review found no high-quality evidence regarding the role of MMA embolization in the management of pCSDH. However, due to its high success rate, MMAE could be a promising approach to treat pCSDH.

Keywords: Chronic subdural hematoma; Middle meningeal artery embolization; Pediatric.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Feghali J, Yang W, Huang J (2020) Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome. World Neurosurg 141:339–345 - DOI - PubMed
    1. Yay MÖ, Wittschieber D, Turgut M (2021) Chronic subdural hematoma in the pediatric population. In: Turgut M, Akhaddar A, Hall WA, Turgut AT (eds) Subdural hematoma. Springer, Cham. https://doi.org/10.1007/978-3-030-79371-5_12
    1. Deora H, Mishra A et al (2022) Paediatric chronic subdural haematoma: what are the predisposing factors and outcomes in management of these cases? Child’s Nervous System 38(1):123–132 - DOI - PubMed
    1. Shapiro M, Walker M et al (2021) Neuroanatomy of cranial dural vessels: implications for subdural hematoma embolization. J Neurointerv Surg 13(5):471–477 - DOI - PubMed
    1. Ironside N, Nguyen C et al (2021) Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta- analysis. J Neurointerv Surg 13(10):951–957 - DOI - PubMed

Publication types

LinkOut - more resources